comparemela.com

Latest Breaking News On - Joseph dal porto - Page 1 : comparemela.com

Second Genome Nominates Development Candidate Targeting PAI-1/2 for the Treatment of Inflammatory Bowel Disease (IBD)

/PRNewswire/ Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers,.

Joseph dal portoKarim dabbaghColitis organizationArena pharmaceuticalsDrug administrationGilead sciences incEuropean crohnChief executive officerSecond genomeChief science officerVirtual plenary hallMucosal healingGilead sciencesHealth care amp hospitalsMedical pharmaceuticalsOlls and research

Uber Health Hires First Chief Medical Officer, Aledade s New CEO, Other Digital Health Appointments

Uber Health appoints first Chief Medical Officer at Uber Health, Aledade appoints Dr. Mandy Cohen will lead Aledade Care Solutions (ACS) as CEO

Republic ofUnited statesNorth carolinaBluff pointCurt thorntonMichael cantorPaul robson elena donioJason srokaAlex peahlBlackford middletonBobbi coluniElena donioCleo tuckerMandy cohenRob cohenJoseph dal porto

Second Genome Appoints Joseph Dal Porto, Ph D , as Chief Scientific Officer

/PRNewswire/ Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers from.

United statesDal portoJoseph dal portoKarim dabbaghJohns hopkins universityArena pharmaceuticalsNational jewish medical research centerUniversity of maryland school medicinePreclinical researchGilead sciences incChief scientificChief executive officerSecond genomeVice presidentEmerging scienceSite head

Second Genome Appoints Joseph Dal Porto, Ph D , as Chief Scientific Officer

/PRNewswire/ Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers from.

United statesDal portoJoseph dal portoKarim dabbaghJohns hopkins universityArena pharmaceuticalsNational jewish medical research centerUniversity of maryland school medicinePreclinical researchGilead sciences incChief scientificChief executive officerSecond genomeVice presidentEmerging scienceSite head

Second Genome Appoints Joseph Dal Porto, Ph D , as Chief Scientific Officer

Second Genome Appoints Joseph Dal Porto, Ph.D., as Chief Scientific Officer - read this article along with other careers information, tips and advice on BioSpace

United statesDal portoJoseph dal portoKarim dabbaghJohns hopkins universityArena pharmaceuticalsNational jewish medical research centerUniversity of maryland school medicinePreclinical researchGilead sciences incChief scientificChief executive officerSecond genomeVice presidentEmerging scienceSite head

vimarsana © 2020. All Rights Reserved.